SEC Form 4 · accession 0001562180-16-002911
Sagent Pharmaceuticals, Inc. · SGNT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Allan Oberman
Officer — Chief Executive Officer · Director
Period of report
Aug 3, 2016
Accepted (ET)
Aug 5, 2016 · 5:17 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001369786
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Aug 3, 2016 | F | 4,271 | $21.74 | D | 101,986 | D |
Table II — derivative securities
No Table II lines on this filing.